Edit
Hookipa Biotech
http://hookipabiotech.com/Last activity: 12.12.2017
Active - Reference to HOOKIPA Pharma Inc.
Hookipa Biotech AG is a privately held, clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology.
Location: Austria
Total raised: $59.6M
Investors 1
| Date | Name | Website |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.12.2017 | Series C | $59.6M | - |
Mentions in press and media 3
| Date | Title | Description |
| 12.12.2017 | Term Sheet — Tuesday, December 12 | 2018 CRYSTAL BALL Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Reply to this email with a one or two-sentence answer to the question: “What’s your top business-related prediction for 2018?... |
| 11.12.2017 | Hookipa Biotech Raises $59.6M in Series C Financing Round | Hookipa Biotech AG, a Vienna, Austria-based clinical stage biotech company, raised $59.6m (€50.0m) in Series C financing. The round was led by an undisclosed blue chip U.S. public investment fund specializing in life sciences, alongside oth... |
| 04.11.2013 | Hookipa Biotech Raises €20M in Series B Equity Financing | Hookipa Biotech AG, a Vienna, Austria-based developer of a new class of vaccines, raised €20m ($27.5m) in Series B equity financing. The roud was led by existing investors Sofinnova Partners and Forbion Capital Partners with participation f... |